¥1.57   ( %)
前日收盘:1.56 当日成交量(股):24.98万 当日最高:1.58 总股本:5148.20万
当日开盘:1.57 当日成交额(元):38.91万 当日最低:1.52 流通股本:
市盈率(动/静):-1.46/-1.48 市净率:3.02 市销率:0 总市值:8031.22万
52周最高:2.95 52周最低:0.88 转让方式: 单位:美元
$ONCOSEC MEDICAL(ONCS)$
  • 还可以输入
  • 20016

ONCOSEC MEDICAL(ONCS) 05月12日 21时31分

新闻 OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Can ......  url.vc.watch/fE84
查看全文

ONCOSEC MEDICAL(ONCS) 05月11日 02时11分

ONCOSEC MEDICAL(ONCS) 05月08日 11时02分

公告 ONCOSEC MEDICAL Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:O/'/Connor Daniel J.
公告日:2018-05-07, 内部交易人:O/'/Connor Daniel J., 与发行人关系:Chief Executive Officer/董事/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-03, SEC Accession No. 0001493152-18-006355, File:https://www.sec.gov/Archives/edgar/data/1444307/000149315218006355/0001493152-18-006355-index.htm $ONCOSEC MEDICAL(ONCS)$
查看全文

ONCOSEC MEDICAL(ONCS) 05月08日 11时02分

公告 ONCOSEC MEDICAL Inc - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:SLANSKY RICHARD B
公告日:2018-05-07, 内部交易人:SLANSKY RICHARD B, 与发行人关系:Chief Financial Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-03, SEC Accession No. 0001493152-18-006354, File:https://www.sec.gov/Archives/edgar/data/1444307/000149315218006354/0001493152-18-006354-index.htm $ONCOSEC MEDICAL(ONCS)$
查看全文

ONCOSEC MEDICAL(ONCS) 05月05日 18时36分

ONCOSEC MEDICAL(ONCS) 05月05日 12时50分

新闻 OncoSec to Present at Eighth Annual BioNJ BioPartnering Conference
SAN DIEGO, May 3, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratu ......  url.vc.watch/fwqq
查看全文

ONCOSEC MEDICAL(ONCS) 04月28日 11时01分

查看全文

ONCOSEC MEDICAL(ONCS) 04月27日 01时35分

新闻 OncoSec Announces PISCES/KEYNOTE-695 Trial-in-Progress Poster Presentation at Upcoming ASCO 2018 Annual Meeting SAN DIEGO, April 26, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (Onco ......  url.vc.watch/fm6T
查看全文

ONCOSEC MEDICAL(ONCS) 04月17日 14时43分

新闻 OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018
SAN DIEGO, April 16, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company de ......  url.vc.watch/X43D
查看全文

ONCOSEC MEDICAL(ONCS) 04月09日 09时04分

新闻 OncoSec to Host Research Reception During the 2018 American Association of Cancer Research Annual Meeting Clinicians to Provide Updates on OncoSec's Intratumoral IL-12 Program in Triple Nega ......  url.vc.watch/Xmx2
查看全文

ONCOSEC MEDICAL(ONCS) 04月07日 09时21分

查看全文

ONCOSEC MEDICAL(ONCS) 03月23日 11时01分

ONCOSEC MEDICAL(ONCS) 03月22日 00时20分

新闻 OncoSec Announces Strategic Relocation Of Office And Laboratories
Relocation Saves $65,000 Per Month and Eliminates $14 Million Long-Term Liability SAN DIEGO, March 20, 2018 /PRNewswire/ -- ......  url.vc.watch/BnDV
查看全文

ONCOSEC MEDICAL(ONCS) 03月17日 00时42分

新闻 OncoSec's Intratumoral IL-12 In Metastatic Triple Negative Breast Cancer (TNBC) Selected For Oral Poster Presentation At The American Association For Cancer Research (AACR) Annual Meetin ......  url.vc.watch/BBs8
查看全文

ONCOSEC MEDICAL(ONCS) 03月17日 00时42分

新闻 OncoSec To Present At The Oppenheimer's 28th Annual Healthcare Conference
SAN DIEGO, March 16, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company deve ......  url.vc.watch/BBsi
查看全文

ONCOSEC MEDICAL(ONCS) 03月13日 23时52分

新闻 OncoSec Announces Dosing of First Patient in Registration-Directed Phase 2b Clinical Trial, PISCES/KEYNOTE-695, of ImmunoPulse® IL-12 in Combination with Pembrolizumab SAN DIEGO, Dec. ......  url.vc.watch/Bi3z
查看全文

ONCOSEC MEDICAL(ONCS) 03月13日 23时52分

新闻 OncoSec Provides 2018 Business Outlook
Complete stage 1 enrollment of PISCES/KEYNOTE-695 clinical trial of ImmunoPulse® IL-12 in combination with KEYTRUDA® (pembrolizumab)Present preliminary ......  url.vc.watch/BitY
查看全文

ONCOSEC MEDICAL(ONCS) 03月13日 23时52分

新闻 OncoSec Appoints Veteran Biopharma Executive Gregory T. Mayes To Board Of Directors
SAN DIEGO, Jan. 16, 2018 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec" or the " ......  url.vc.watch/Bita
查看全文

ONCOSEC MEDICAL(ONCS) 03月13日 23时52分

新闻 OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study
SAN DIEGO, Jan. 18, 2018 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec" ......  url.vc.watch/BitF
查看全文

ONCOSEC MEDICAL(ONCS) 03月13日 23时52分

新闻 OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
SAN DIEGO, Jan. 31, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS), a biotechnology company ......  url.vc.watch/Bitu
查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共131